Business Litigation - Written by Jere Beasley on Tuesday, October 7, 2008 9:39 - 0 Comments

Fraud claims proceed against Bristol-Myers executive

bodnar 263x280A Manhattan federal judge has ruled that the U.S. Supreme Court’s recent ruling in Stoneridge Investment Partners v. Scientific-Atlanta Inc., doesn’t shield a Bristol-Myers Squibb Co. executive from securities claims. The executive made no public statements, but his behavior was central to the company’s alleged misconduct. Bristol-Myers shareholders are suing the company and two of its top executives for allegedly misleading them about patent against Apotex, a manufacturer of a generic version of Bristol-Myers’ best-selling Plavix blood-thinning drug. According to shareholders, the company bargained away much of its right to seek damages for patent infringement to strike a licensing deal with Apotex that was subsequently rejected by regulators.


The company allegedly concealed the extent to which it had hamstrung its options and publicly stated it would “vigorously pursue” patent against Apotex. Andrew Bodnar, Bristol-Myers’ former senior vice president for strategy, carried out the negotiations with Apotex, but made no public statements about them. The Stoneridge decision limited liability for securities by actors who were “too remote” from investors. But the district judge rejected that argument stating:

Bodnar made no public statements himself, but investors relied on his good faith in negotiating the Apotex agreement and committing the company to its terms.

The judge also denied motions to dismiss by Bristol-Myers and former chief executive Peter Dolan. Bodnar was indicted in April for concealing the negotiations with Apotex from the Federal Trade Commission.

Source: Law.com




Leave a Reply

Comment

Comments are moderated and generally will be posted if they are on-topic and not abusive.

Powered by WP Hashcash

Personal Injury, Recent Settlements - Jul 19, 2010 14:03 - 0 Comments

Wrongful Death Settlement In Civil Damages Act

More In Recent Settlements


Product Liability - Jul 31, 2010 15:21 - 0 Comments

Reclining Seats Are A Hidden Danger

More In Product Liability


Recalls Update - Aug 19, 2010 12:24 - 0 Comments

Prescription Cat Food Recalled

More In Recalls Update